Maiwald Blog

Maiwald blog articles

European Patent Office: Oral proceedings via video conference become standard

On 22 November 2022, a decision by the President of the European Patent Office (EPO) was issued that from January 1, 2023, onwards oral proceedings before the first instance (...

Continue reading

No trademark infringement by model designation even in case of double identity

If the question in infringement cases is usually whether the opposing goods and signs are similar, claims by the trademark owner can, however, also fail at an earlier ...

Continue reading

New timetable for the UPC: launch planned for 1 April 2023

On 6 October 2022, the Preparatory team for the Unified Patent Court...

Continue reading

No Interruption of Forfeiture Periods in the Event of Negligent Legal Action

In a recent judgment, the ECJ has now clarified under which conditions a cease and desist letter can interrupt forfeiture periods (ECJ GRUR 2022, 986 - HEITEC.). Accor...

Continue reading

News from Brussels – Stricter rules on pesticides and human substances for medical treatments & therapies

In the past few weeks the EU Commission made several legislative proposals in the areas of chemistry/food safety and safety of (medical) products. Two of those topics we would...

Continue reading

Free samples of medicinal products to pharmacists – Section 7 (1) Health Services and Products Advertising Act (HWG) 

Higher Regional Court, Frankfurt am Main, judgment dated 10 February 2022, Case No. 6 U 161/15 As reported here on

Continue reading